15 September 2026 : Original article
Four Years of Clinical Experience With COVID-19 Outcomes in Heart Transplant Recipients
Agnieszka Kuczaj
ABCDEFG 1*, Szymon Warwas BCDEF 1, Mikołaj Tyrka BDEF 1, Błażej Skotnicki BDEF 1, Daniel Szymecki BDEF 1, Oliwia Jewuła BDEF 1, Joanna Śliwka ADEF 1, Szymon Pawlak ADEF 1, Piotr Przybyłowski ADEF 1, Tomasz Hrapkowicz ADEF 1
DOI: 10.12659/AOT.952888
Ann Transplant 2026; 31:e952888
Table 2 Univariable analysis of the clinical factors related to death due to COVID-19.
| Clinical data | Odds ratio | 95% CI | P value |
|---|---|---|---|
| Obesity (BMI > 30 kg/m) | 1.74 | 0.64–4.74 | 0.28 |
| Body mass index (kg/m) | 1.09 | 0.99–1.2 | 0.08 |
| Male sex | 2.55 | 0.58–11.23 | 0.22 |
| Arterial hypertension | 4.78 | 0.63–36.38 | 0.13 |
| Vaccinated | 0.32 | 0.11–0.94 | 0.04 |
| Diabetes mellitus type 2 | 3.25 | 1.05–10.1 | 0.04 |
| Age (years) | 1.06 | 1.01–1.11 | 0.01 |
| Creatinine level (μmol/L) | 1.003 | 1.000–1.006 | 0.03 |